fashion -WSS

fashion

author：comprehensive 2025-09-06 03:32:31 - browse：53567

Two people run on the sugar-phosphate backbone of DNA while holding base pairs — in the lab coverage from STAT — Adobe

LONDON — Widespread genetic testing as well as the development of cutting-edge, customized genetic therapies have opened the door to treating many more inherited conditions than previously possible. A few recent cases, in which bespoke medicines were created for children with exceedingly rare mutations, have raised hopes for furthering the approach.

Now, researchers and government agencies in the U.K. are trying to figure out the nitty-gritty to replicate those early one-off successes for as many patients as possible — what sort of preclinical testing a tailor-made treatment needs to go through before being used, what regulatory thresholds each treatment needs to clear, and how to pay for these therapies.

“A lot of the barriers are no longer scientific — we can make these drugs,” said Matthew Wood, a professor of pediatrics at the University of Oxford. “It’s more about, can we make them at a cost that is reasonable enough? And can we get the regulators to reduce the barriers to doing this so that when a patient shows up, you can actually make a drug quickly enough to benefit that patient, rather than it costing huge amounts of money and taking two or three years to do it?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Transgender sports debate: Physicians say bans are health issue

entertainment

WSS

PBMs drew scrutiny in House hearing — and so did pharma

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Just how do doctors, lawmakers, and the public define abortion?

Sen. Paul opposes bill to ban Chinese biotechs

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Chamber of Commerce, DOJ clash in court over drug prices

Wikipedia

fashion

hotspot

Supreme Court strikes down use of affirmative action

Eli Lilly CEO gives to Mike Pence presidential super PAC

Bright Health sells Medicare Advantage business to Molina

Fed up with FDA, ALS advocates consider a take

Apple is now the first public company to be valued at $3 trillion

How the messy conversation about Dolly changed bioethics

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Free Covid tests will again be offered to all U.S. households

Sports medicine is finally prioritizing gender equality

Chamber of Commerce, DOJ clash in court over drug prices

hotspot

Novo Nordisk obesity pill bests Wegovy in early trial

Akili changes sales model for its ADHD video game treatment

Information blocking fines are now fair game in health care

With psoriasis trial ahead, Alumis raises $259 million

Senate bill would ban some hospital facility fees

Free Covid tests will again be offered to all U.S. households

entertainment

knowledge

focus

leisure time